Compare $VCEL vs $VERA | Chartloom

Compare

$VCEL vs $VERA

Vericel Corp · Vera Therapeutics, Inc

VCEL

Vericel Corp

VERA

Vera Therapeutics, Inc

Compare $VCEL vs $VERA

Comparing Vericel Corp and Vera Therapeutics, Inc

VCELVericel Corp

VERAVera Therapeutics, Inc

VCELVericel Corp

Market cap

$2.05B

P/E (TTM)

86.61x

Forward P/E (NTM)

55.49x

Forward P/S (NTM)

5.56x

Rev growth (TTM)

23.0%

YTD performance

12.6%

52W performance

17.5%

FCF yield

3.0%

VERAVera Therapeutics, Inc

Market cap

$2.14B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.87x

Rev growth (TTM)

—

YTD performance

-38.5%

52W performance

-2.0%

FCF yield

-15.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

VCEL

VERA

Detailed metrics comparison

VCEL

Vericel Corp

VERA

Vera Therapeutics, Inc

Market Cap

VCEL$2.05B

VERA$2.14B

Enterprise Value

VCEL$1.92B

VERA$2.17B

Price

VCEL$40.10

VERA$29.88

P/E Ratio

VCEL86.61x

VERAN/A

P/S Ratio

VCEL6.69x

VERA0.00x

EV/Sales

VCEL6.28x

VERA0.00x

EV/EBITDA

VCEL58.45x

VERA0.00x

P/B Ratio

VCEL5.56x

VERA5.38x

P/FCF Ratio

VCEL33.21x

VERAN/A

EV/FCF

VCEL31.19x

VERA-6.40x

PEG Ratio

VCEL0.32x

VERAN/A

Forward P/E (NTM)

VCEL55.49x

VERAN/A

Forward P/S (NTM)

VCEL5.56x

VERA19.87x

Revenue (TTM)

VCEL$306M

VERA$0

Revenue Growth (YoY)

VCEL23.0%

VERAN/A

Forward Rev Growth

VCEL16.9%

VERA698.6%

Gross Margin (TTM)

VCEL74.6%

VERA0.0%

Operating Margin (TTM)

VCEL6.0%

VERA0.0%

EBITDA Margin (TTM)

VCEL10.2%

VERA0.0%

Net Margin (TTM)

VCEL7.9%

VERA0.0%

FCF Margin (TTM)

VCEL20.1%

VERAN/A

Net Income (TTM)

VCEL$24M

VERA$-402M

FCF (TTM)

VCEL$62M

VERA$-339M

EPS (TTM)

VCEL$0.46

VERA-$5.59

ROE (TTM)

VCEL6.9%

VERA-8413.0%

ROA (TTM)

VCEL5.0%

VERA-6679.0%

ROIC (TTM)

VCEL6.9%

VERA-7272.0%

Cash

VCEL$125M

VERA$49M

Debt

VCEL$596K

VERA$75M

Net Cash/Debt

VCEL$125M

VERA$-26M

Current Ratio (TTM)

VCEL5.04x

VERA10.92x

Quick Ratio (TTM)

VCEL4.69x

VERA10.50x

Debt/Equity (TTM)

VCEL0.00x

VERA0.18x

Debt/Assets (TTM)

VCEL0.0%

VERA0.0%

Interest Coverage (TTM)

VCELN/A

VERAN/A

Net Debt/EBITDA (TTM)

VCEL0.00x

VERA0.00x

Beta

VCEL1.06

VERA1.13

52W Performance

VCEL17.5%

VERA-2.0%

YTD Performance

VCEL12.6%

VERA-38.5%

% from 52W High

VCEL-18.7%

VERA-46.7%

% from 52W Low

VCEL38.5%

VERA29.6%

Asset Turnover (TTM)

VCEL0.63x

VERA0.00x

FCF Yield (TTM)

VCEL3.0%

VERA-15.8%

Earnings Yield (TTM)

VCEL1.2%

VERA-18.7%

Dividend Yield (TTM)

VCELN/A

VERAN/A

Rule of 40

VCEL43.1

VERA0.0

EV/GP/RG

VCEL0.39

VERAN/A

Ticker research

View VCEL research View VERA research

Metric	VCEL Vericel Corp	VERA Vera Therapeutics, Inc
Market & Valuation
Market Cap	$2.05B	$2.14B
Enterprise Value	$1.92B	$2.17B
Price	$40.10	$29.88
P/E Ratio	86.61x	N/A
P/S Ratio	6.69x	0.00x
EV/Sales	6.28x	0.00x
EV/EBITDA	58.45x	0.00x
P/B Ratio	5.56x	5.38x
P/FCF Ratio	33.21x	N/A
EV/FCF	31.19x	-6.40x
PEG Ratio	0.32x	N/A
Forward P/E (NTM)	55.49x	N/A
Forward P/S (NTM)	5.56x	19.87x
Revenue & Growth
Revenue (TTM)	$306M	$0
Revenue Growth (YoY)	23.0%	N/A
Forward Rev Growth	16.9%	698.6%
Profitability
Gross Margin (TTM)	74.6%	0.0%
Operating Margin (TTM)	6.0%	0.0%
EBITDA Margin (TTM)	10.2%	0.0%
Net Margin (TTM)	7.9%	0.0%
FCF Margin (TTM)	20.1%	N/A
Net Income (TTM)	$24M	$-402M
FCF (TTM)	$62M	$-339M
EPS (TTM)	$0.46	-$5.59
ROE (TTM)	6.9%	-8413.0%
ROA (TTM)	5.0%	-6679.0%
ROIC (TTM)	6.9%	-7272.0%
Financial Health
Cash	$125M	$49M
Debt	$596K	$75M
Net Cash/Debt	$125M	$-26M
Current Ratio (TTM)	5.04x	10.92x
Quick Ratio (TTM)	4.69x	10.50x
Debt/Equity (TTM)	0.00x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.06	1.13
52W Performance	17.5%	-2.0%
YTD Performance	12.6%	-38.5%
% from 52W High	-18.7%	-46.7%
% from 52W Low	38.5%	29.6%
Efficiency & Yields
Asset Turnover (TTM)	0.63x	0.00x
FCF Yield (TTM)	3.0%	-15.8%
Earnings Yield (TTM)	1.2%	-18.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	43.1	0.0
EV/GP/RG	0.39	N/A
Ticker research	View VCEL research	View VERA research

Valuation

P/E Ratio

VCEL

86.61x

P/S Ratio

VERA

0.00x

VCEL

6.69x

EV/FCF

VERA

-6.40x

VCEL

31.19x

Growth & revenue

Revenue Growth TTM

VCEL

23.0%

Forward Revenue Growth

VERA

698.6%

VCEL

16.9%

Profitability & performance

Gross Margin

VCEL

74.6%

VERA

0.0%

ROE

VCEL

6.9%

VERA

-8413.0%

FCF Yield %

VCEL

3.0%

VERA

-15.8%

52-Week Performance

VCEL

17.5%

VERA

-2.0%

Detailed metrics comparison

VCEL

Vericel Corp

VERA

Vera Therapeutics, Inc

Market Cap

VCEL$2.05B

VERA$2.14B

Enterprise Value

VCEL$1.92B

VERA$2.17B

Price

VCEL$40.10

VERA$29.88

P/E Ratio

VCEL86.61x

VERAN/A

P/S Ratio

VCEL6.69x

VERA0.00x

EV/Sales

VCEL6.28x

VERA0.00x

EV/EBITDA

VCEL58.45x

VERA0.00x

P/B Ratio

VCEL5.56x

VERA5.38x

P/FCF Ratio

VCEL33.21x

VERAN/A

EV/FCF

VCEL31.19x

VERA-6.40x

PEG Ratio

VCEL0.32x

VERAN/A

Forward P/E (NTM)

VCEL55.49x

VERAN/A

Forward P/S (NTM)

VCEL5.56x

VERA19.87x

Revenue (TTM)

VCEL$306M

VERA$0

Revenue Growth (YoY)

VCEL23.0%

VERAN/A

Forward Rev Growth

VCEL16.9%

VERA698.6%

Gross Margin (TTM)

VCEL74.6%

VERA0.0%

Operating Margin (TTM)

VCEL6.0%

VERA0.0%

EBITDA Margin (TTM)

VCEL10.2%

VERA0.0%

Net Margin (TTM)

VCEL7.9%

VERA0.0%

FCF Margin (TTM)

VCEL20.1%

VERAN/A

Net Income (TTM)

VCEL$24M

VERA$-402M

FCF (TTM)

VCEL$62M

VERA$-339M

EPS (TTM)

VCEL$0.46

VERA-$5.59

ROE (TTM)

VCEL6.9%

VERA-8413.0%

ROA (TTM)

VCEL5.0%

VERA-6679.0%

ROIC (TTM)

VCEL6.9%

VERA-7272.0%

Cash

VCEL$125M

VERA$49M

Debt

VCEL$596K

VERA$75M

Net Cash/Debt

VCEL$125M

VERA$-26M

Current Ratio (TTM)

VCEL5.04x

VERA10.92x

Quick Ratio (TTM)

VCEL4.69x

VERA10.50x

Debt/Equity (TTM)

VCEL0.00x

VERA0.18x

Debt/Assets (TTM)

VCEL0.0%

VERA0.0%

Interest Coverage (TTM)

VCELN/A

VERAN/A

Net Debt/EBITDA (TTM)

VCEL0.00x

VERA0.00x

Beta

VCEL1.06

VERA1.13

52W Performance

VCEL17.5%

VERA-2.0%

YTD Performance

VCEL12.6%

VERA-38.5%

% from 52W High

VCEL-18.7%

VERA-46.7%

% from 52W Low

VCEL38.5%

VERA29.6%

Asset Turnover (TTM)

VCEL0.63x

VERA0.00x

FCF Yield (TTM)

VCEL3.0%

VERA-15.8%

Earnings Yield (TTM)

VCEL1.2%

VERA-18.7%

Dividend Yield (TTM)

VCELN/A

VERAN/A

Rule of 40

VCEL43.1

VERA0.0

EV/GP/RG

VCEL0.39

VERAN/A

Ticker research

View VCEL research View VERA research

Metric	VCEL Vericel Corp	VERA Vera Therapeutics, Inc
Market & Valuation
Market Cap	$2.05B	$2.14B
Enterprise Value	$1.92B	$2.17B
Price	$40.10	$29.88
P/E Ratio	86.61x	N/A
P/S Ratio	6.69x	0.00x
EV/Sales	6.28x	0.00x
EV/EBITDA	58.45x	0.00x
P/B Ratio	5.56x	5.38x
P/FCF Ratio	33.21x	N/A
EV/FCF	31.19x	-6.40x
PEG Ratio	0.32x	N/A
Forward P/E (NTM)	55.49x	N/A
Forward P/S (NTM)	5.56x	19.87x
Revenue & Growth
Revenue (TTM)	$306M	$0
Revenue Growth (YoY)	23.0%	N/A
Forward Rev Growth	16.9%	698.6%
Profitability
Gross Margin (TTM)	74.6%	0.0%
Operating Margin (TTM)	6.0%	0.0%
EBITDA Margin (TTM)	10.2%	0.0%
Net Margin (TTM)	7.9%	0.0%
FCF Margin (TTM)	20.1%	N/A
Net Income (TTM)	$24M	$-402M
FCF (TTM)	$62M	$-339M
EPS (TTM)	$0.46	-$5.59
ROE (TTM)	6.9%	-8413.0%
ROA (TTM)	5.0%	-6679.0%
ROIC (TTM)	6.9%	-7272.0%
Financial Health
Cash	$125M	$49M
Debt	$596K	$75M
Net Cash/Debt	$125M	$-26M
Current Ratio (TTM)	5.04x	10.92x
Quick Ratio (TTM)	4.69x	10.50x
Debt/Equity (TTM)	0.00x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.06	1.13
52W Performance	17.5%	-2.0%
YTD Performance	12.6%	-38.5%
% from 52W High	-18.7%	-46.7%
% from 52W Low	38.5%	29.6%
Efficiency & Yields
Asset Turnover (TTM)	0.63x	0.00x
FCF Yield (TTM)	3.0%	-15.8%
Earnings Yield (TTM)	1.2%	-18.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	43.1	0.0
EV/GP/RG	0.39	N/A
Ticker research	View VCEL research	View VERA research